|
Market Closed -
Deutsche Boerse AG
23:44:40 01/10/2026 +04
|
After hours 23:59:59 | |||
| 168.92 EUR | +0.06% |
|
168.13 | -0.47% |
| 10-01 | Moderna, Inc. Announces Management Changes | CI |
| 10-01 | S&P 500 dips, Nasdaq higher after data shows moderate inflation rise | RE |
| Market Cap | 76.88B 68.29B 63.86B 58.19B 110B 7,402B 111B 773B 299B 3,770B 289B 282B 12,108B | P/E 2026 * |
-23x | P/E 2027 * | -40.2x |
|---|---|---|---|---|---|
| Enterprise Value | 73.23B 65.04B 60.82B 55.43B 104B 7,050B 106B 736B 285B 3,591B 275B 269B 11,533B | EV / Sales 2026 * |
34.9x | EV / Sales 2027 * | 30.7x |
| Free-Float |
92.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRNA | Delayed | |
CBOE
| MRNA | Real-time | |
|
Tradegate
| 0QF | Real-time | |
|
Borsa Italiana
| 1MRNA | End-of-day quote | |
|
Xetra
| 0QF | Delayed | |
|
Boerse Muenchen
| 0QF | Real-time | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| MRNA * | End-of-day quote | |
|
CBOE
| 0A45 | Real-time | |
|
Börse Stuttgart
| 0QF | Delayed | |
|
Swiss Exchange
| MRNA | Delayed | |
|
London S.E.
| 0A45 | Delayed | |
|
Deutsche Boerse AG
| 0QF | Delayed | |
|
Kazakhstan S.E.
| MRNA_KZ | End-of-day quote | |
|
Wiener Boerse
| MRNA | End-of-day quote | |
|
Lima
| MRNAUS | End-of-day quote | |
|
Swiss Exchange
| MRNA | Delayed |
Last Transcript: Moderna, Inc.
| 1 day | -0.41% | ||
| 1 week | +5.61% | ||
| Current month | +0.06% | ||
| 1 month | +36.78% | ||
| 3 months | +178.70% | ||
| 6 months | +290.75% | ||
| Current year | +534.44% |
| 1 week | 162.96 |  | 183.4 |
| 1 month | 112.96 | | 183.4 |
| Current year | 25.28 | | 183.4 |
| 1 year | 19.26 | | 183.4 |
| 3 years | 19.26 | | 183.4 |
| 5 years | 19.26 | | 332.3 |
| 10 years | 10.8 | | 432.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +5.61% | - | - | 76.88B | |
| -0.62% | -2.71% | +39.30% | +113.61% | 1,031B | |
| -2.30% | -4.44% | +39.03% | +66.72% | 638B | |
| -0.63% | -1.96% | +6.36% | +75.33% | 462B | |
| -1.03% | -2.82% | +59.56% | +40.23% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.30% | +36.44% | +52.93% | 228B | |
| -1.04% | -1.46% | +32.70% | +99.06% | 185B | |
| Average | -1.12% | -0.36% | +30.36% | +57.93% | 418.21B | |
| Weighted average by Cap. | -0.98% | -0.35% | +32.51% | +69.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.1B 1.87B 1.75B 1.59B 2.99B 202B 3.04B 21.11B 8.17B 103B 7.89B 7.72B 331B | 2.43B 2.16B 2.02B 1.84B 3.47B 234B 3.52B 24.46B 9.47B 119B 9.14B 8.94B 383B |
| Net income | -3.31B -2.94B -2.75B -2.51B -4.72B -319B -4.78B -33.27B -12.88B -162B -12.43B -12.16B -522B | -1.95B -1.73B -1.62B -1.47B -2.77B -187B -2.81B -19.56B -7.57B -95.45B -7.31B -7.15B -307B |
| Net Debt | -3.65B -3.24B -3.03B -2.76B -5.21B -352B -5.28B -36.71B -14.21B -179B -13.71B -13.42B -575B | -2.17B -1.93B -1.8B -1.64B -3.09B -209B -3.13B -21.8B -8.44B -106B -8.15B -7.97B -342B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | €168.92 | +0.06% | 1,734 |
| 30/09/26 | €168.82 | -6.22% | 2,196 |
| 29/09/26 | €180.02 | +3.72% | 1,606 |
| 28/09/26 | €173.56 | +0.24% | 1,872 |
| 25/09/26 | €173.14 | +2.03% | 1,548 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
- 0QF Stock
Select your edition
All financial news and data tailored to specific country editions
